Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02222922
Title A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer

Advanced Solid Tumor

ovarian cancer

lung non-small cell carcinoma

triple-receptor negative breast cancer


Avelumab + Cofetuzumab pelidotin


Cofetuzumab pelidotin

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.